News
To the Millions of Americans Who Rely on Lilly Insulin
View Story
COVID-19 Update on Insulin Affordability and Supply
View Story
Updates: Lilly's Global COVID-19 Response
View Story
Dave Ricks Shares Thoughts on 2019
View Story
In Bolivia, Life for a Child Helps a Youth Achieve His Dream
View Story
Gemologist Benefits from Insulin Affordability Program
View Story
April 1, 2020
Tags | Corporate Responsibility
KENILWORTH, N.J. & NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)--Apr. 1, 2020-- Merck & Co., Inc., (NYSE: MRK), Pfizer Inc. (NYSE: PFE), and Eli Lilly and Company (NYSE: LLY) today announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.
April 1, 2020
Tags | Corporate Responsibility
INDIANAPOLIS, April 1, 2020 – Governor Eric J. Holcomb and Mayor Joe Hogsett – and a coalition of statewide business and community partners including Eli Lilly and Company – announced a social distancing campaign to help flatten the curve for COVID-19 in Indiana.
March 31, 2020
Tags | Corporate
INDIANAPOLIS and OXFORD, England , March 31, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in
March 30, 2020
Tags | Product
-- Taltz is the first and only IL-17A antagonist approved to treat this population -- INDIANAPOLIS , March 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for